Allergic rhinoconjunctivitis: Burden of disease
The DOI matches its Crossref record.
Abstract
Even though there is no mortality associated with allergic rhinoconjunctivitis (AR), there is significant morbidity in sufferers of this condition. The exact number of patients with AR is difficult to ascertain, with studies showing ranges from 9 to 42% of the population. Recently, the Allergies in America survey found that 14.2% of the adult U.S. population has been diagnosed with AR. It is well established that AR has a profound influence on the patient's quality of life. Not only do people with AR complain of rhinorrhea, nasal congestion, sneezing, itching, and associated eye problems disturbing, but they also have impaired emotional wellbeing and social functioning. Costs are a major burden in AR studies showing at least $6 billion/year. Although most attention related to costs in AR have been evaluating direct costs due to physician consultation and medical treatment, it is now clear that indirect costs are a major aspect of total costs in AR, especially for American businesses. Indirect costs include absenteeism from work or school because of illness and decreased productivity when at work or presenteeism. AR should be treated seriously by the medical community. Proper treatment of AR patients should not only greatly improve their quality of life, but also bring down health care costs, especially indirect ones, associated with this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The economic impact of allergic rhinitis and current guidelines for treatment
Meltzer, E. O., & Bukstein, D. A. (2011) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.10.014 · Cited by 268
The microbiota, immunoregulation, and mental health: implications for public health
Lowry, C. A., Smith, D. G., Siebler, P. H., Schmidt, D., Stamper, C. E., Hassell, J. E., Yamashita, P. S., Fox, J. H., Reber, S. O., Brenner, L. A., et al. (2016) · Current Environmental Health Reports · doi:10.1007/s40572-016-0100-5 · Cited by 172
Diagnosis and management of allergic conjunctivitis in pediatric patients
Berger, W. E., Granet, D. B., & Kabat, A. G. (2017) · Allergy and Asthma Proceedings · doi:10.2500/aap.2017.38.4003 · Cited by 35
Katelaris, C. H., Sacks, R., & Theron, P. N. (2013) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2013.27.3965 · Cited by 32
Metadata
- Authors
- Blaiss, M. S.
- Venue
- Allergy and Asthma Proceedings
- Publisher
- Oceanside Publications Inc.
- Published
- 2007-07-01
- Volume
- 28
- Issue
- 4
- Pages
- 393-397
- ISSN
- 1088-5412 (ISSN-L)
- OpenAlex
- W1995090363
- Cited by
- 88
- References
- 0
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Allergic rhinoconjunctivitis: Burden of disease. https://app.cochat.ai/papers/10.2500/aap.2007.28.3013
- The paper
- Blaiss, M. S. (2007). Allergic rhinoconjunctivitis: Burden of disease. Allergy and Asthma Proceedings. https://doi.org/10.2500/aap.2007.28.3013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.